SLAMF1 Antikörper (AA 231-335) (AbBy Fluor® 594)
-
- Target Alle SLAMF1 Antikörper anzeigen
- SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))
-
Bindungsspezifität
- AA 231-335
-
Reaktivität
- Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLAMF1 Antikörper ist konjugiert mit AbBy Fluor® 594
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Maus, Ratte
- Homologie
- Human,Dog,Cow,Sheep,Pig,Horse
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CD150
- Isotyp
- IgG
- Top Product
- Discover our top product SLAMF1 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))
- Andere Bezeichnung
- CD150 (SLAMF1 Produkte)
- Synonyme
- CD150 antikoerper, SLAM antikoerper, SLAMF1 antikoerper, 4933415F16 antikoerper, AA177906 antikoerper, CDw150 antikoerper, ESTM51 antikoerper, IPO-3 antikoerper, Slam antikoerper, RGD1560634 antikoerper, signaling lymphocytic activation molecule family member 1 antikoerper, SLAMF1 antikoerper, Slamf1 antikoerper
- Hintergrund
-
Synonyms: SLAM, CD150, CDw150, Signaling lymphocytic activation molecule, IPO-3, SLAMF1
Background: High-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.
- Gen-ID
- 6504
- UniProt
- Q13291
-